A Study of Ponsegromab in People With Heart Failure – Cohort B Results
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, 4-Arm Study to Investigate Symptoms, Function, Health-Related Quality of Life and Safety With Repeated Subcutaneous Administration of Ponsegromab Versus Placebo in Adult Participants with Heart Failure.
Category & Conditions: Cancer
Medicine: PF-06946860
ClinicalTrials.gov Identifier (NCT): NCT05492500
Protocol ID: C3651011
Open Plain Language Summary Result:
Click here